Regenerative medicine applied to Spinal Cord Injury and Acquired Brain Damage

The Institut Guttmann has integrated cutting edge technologies and developed innovative methodology under the vision to become an optimal Clinical Research Center for advanced therapies and regenerative medicine in neurorehabilitation.

The objectives of this program are:

  • Establishing a clinical trials unit to assess the safety and efficacy of regenerative medicine interventions applied to spinal cord injury and acquired brain injury in the Institut Guttmann.

  • Develop a biobased data from information derived typing of patients clinically (functional and structural); subclinical (neurophysiological and structural, by structural, functional neuroimaging and genetics) used for the selection of candidates for this type of studies.

  • Promote the establishment of strategic alliances with research centers in cell engineering to identify the most suitable for the problems of our patient population strategies.

  • Promote the introduction of robotic systems and the structuring of rehabilitation programs that allow systematic monitoring of the intervention in neurorehabilitation as an active component of neuroregenerative therapies.

    2.5-MedicRegenerat-01

 

 

PROYECTO

  • “A prospective, open-label, Intrathecal injection single-dose, phase I/IIa pilot study to assess the safety and to obtain preliminary efficacy results of allogenic stem cells from umbilical cord transplantation in patients with complete chronic traumatic spinal cord injury”, Financiado por la Fundació La Marató de TV3, convocatoria de ayudas 2012 – 616/2012